Glomerular disease in 2016: New advances in the treatment of glomerular disease

Nature Reviews Nephrology 13, 65 (2017). doi:10.1038/nrneph.2016.195 Authors: Rutger J. Maas & Jack F. Wetzels Studies published in 2016 provide insights that bring us closer to achieving the goal of personalized therapy for primary glomerular diseases. Moreover, promising renal outcome data with new classes of glucose-lowering agents — SGLT2 inhibitors and GLP-1 agonists — offer new hope for patients with diabetic nephropathy.
Source: Nature Reviews Nephrology - Category: Urology & Nephrology Authors: Tags: Year in Review Source Type: research